Australian Autism Biobank launched
at Wesley Medical Research
Australia’s first Autism Biobank was officially launched at Wesley Medical Research on Monday, 21 March at 12pm, by the Hon. Sussan Ley, Minister for Health.
Stored at the ABB Wesley Medical Research Tissue Bank, one of the key bio-resources in Queensland for medical research, the Australian Autism Biobank will be an asset highly sought after by researchers from around the world.
“The Australian Autism Biobank is a wonderful example of the advantages of cooperative clinical research. Banks such as these link clinical information with biological specimens, allowing scientists and doctors to join forces in their research. Wesley Medical Research has a number of other such repositories, providing a huge advantage for Australian clinical research,” said Professor David Paterson, CEO of Wesley Medical Research.
The Australian Autism Biobank, pioneered by the Cooperative Research Centre for Living with Autism (Autism CRC), will contain a detailed phenotypic and genotypic profile of each donor providing a rich and unique dataset of almost 5,000 individuals, developing a valuable asset for Australian researchers and their international collaborators.
Increasing numbers of children have been diagnosed with autism in the past 10 years with a greater awareness of autism and changes in the diagnostic criteria. However, with no current established biomarker for autism, diagnosis relies solely on behavourial profiling.